E-LIB Suche - Ergebnisse für: Miller, Rowan E.

1

Monitoring clone dynamics and reversibility in clonal haema..:

Nuttall Musson, Ellen ; Miller, Rowan E. ; Mansour, Marc R....
Leukemia. 38 (2023) 1 - p. 215-218 , 2023

Link: https://doi.org/10.1038/..

2

The Landscape of Adoptive Cellular Therapies in Ovarian Can..:

Davis, Lucy ; Miller, Rowan E ; Wong, Yien Ning Sophia
Cancers. 15 (2023) 19 - p. 4814 , 2023

Link: https://doi.org/10.3390/..

3

Patient decision aids in mainstreaming genetic testing for ..:

Sobocan, Monika ; Chandrasekaran, Dhivya ; Sideris, Michail...
BJOG: An International Journal of Obstetrics & Gynaecology. 131 (2023) 6 - p. 848-857 , 2023

Link: https://doi.org/10.1111/..

4

The role of PARP inhibitor combination therapy in ovarian c..:

Hockings, Helen ; Miller, Rowan E.
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592311731 , 2023

Link: https://doi.org/10.1177/..

5

Disparity in the era of personalized medicine for epithelia..:

Devlin, Michael-John ; Miller, Rowan E.
Therapeutic Advances in Medical Oncology. 15 (2023) - p. 175883592211480 , 2023

Link: https://doi.org/10.1177/..

6

Recent trends in molecular testing and maintenance targeted..:

Darwish, Ahmed ; Elyashiv, Osnat ; Graham, Radha.
The Obstetrician & Gynaecologist. 25 (2023) 3 - p. 220-228 , 2023

Link: https://doi.org/10.1111/..

7

Seminoma and dysgerminoma: evidence for alignment of clinic..:

Wood, Georgina E. ; Bunting, Christopher P. ; Veli, Mesel...
Frontiers in Oncology. 13 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

First-in-human phase I/II, open-label study of the anti-OX4..:

Davis, Elizabeth J ; Martin-Liberal, Juan ; Kristeleit, Rebecca...
Journal for ImmunoTherapy of Cancer. 10 (2022) 10 - p. e004235 , 2022

Link: https://doi.org/10.1136/..

9

Management of Recurrent Ovarian Cancer:

, In: Advances in Diagnosis and Management of Ovarian Cancer,

Kotsopoulos, Ioannis C. ; Miller, Rowan E. ; Mould, Timothy A. - p. 121-128 , 2022

Link: https://doi.org/10.1007/..

10

PARP inhibitors in ovarian cancer: overcoming resistance wi..:

Miller, Rowan E ; El-Shakankery, Karim H ; Lee, Jung-Yun
Journal of Gynecologic Oncology. 33 (2022) 3 - p. , 2022

Link: https://doi.org/10.3802/..

11

Ovarian Cancer Therapy: Homologous Recombination Deficiency..:

Miller, Rowan E ; Elyashiv, Osnat ; El-Shakankery, Karim H.
OncoTargets and Therapy. 15 (2022) - p. 1105-1117 , 2022

Link: https://doi.org/10.2147/..

12

Implementation of Multigene Germline and Parallel Somatic G..:

Chandrasekaran, Dhivya ; Sobocan, Monika ; Blyuss, Oleg...
Cancers. 13 (2021) 17 - p. 4344 , 2021

Link: https://doi.org/10.3390/..

13

PARP inhibitors and immunotherapy in ovarian and endometria..:

Miller, Rowan E ; Lewis, Amy J ; Powell, Melanie E
The British Journal of Radiology. 94 (2021) 1128 - p. , 2021

Link: https://doi.org/10.1259/..

14

Targeting HPV in gynaecological cancers – Current status, o..:

Crusz, Shanthini M ; El-Shakankery, Karim ; Miller, Rowan E
Women's Health. 16 (2020) - p. 174550652096170 , 2020

Link: https://doi.org/10.1177/..

15

Body Mass Index and Outcomes in Germ-Cell Tumors:

McGregor, Bradley A. ; Miller, Rowan E. ; O'Donnell, Elizabeth...
Clinical Genitourinary Cancer. 17 (2019) 4 - p. 283-290 , 2019

Link: https://doi.org/10.1016/..